Liquid risperidone in the treatment of rages in psychiatrically hospitalized children with possible bipolar disorder

Bipolar Disorders

Volumn 12, Issue 2, 2010, Pages 205-212

  Carlson, Gabrielle A ^a   Potegal, Michael ^b   Margulies, David ^a   Basile, Joann ^c   Gutkovich, Zinoviy ^d  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^d ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

ADHD; Aggression; Atypical antipsychotics; Bipolar; Child; Mania; Psychopharmacology; Rages; Risperidone

Indexed keywords

RISPERIDONE; NEUROLEPTIC AGENT; SOLUTION AND SOLUBILITY;

AKATHISIA; ARTICLE; BIPOLAR DISORDER; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INVOLUNTARY MOVEMENT; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SCHOOL CHILD; SEDATION; SEMI STRUCTURED INTERVIEW; SIDE EFFECT; SOMNOLENCE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; ADMINISTRATION AND DOSAGE; DRUG EFFECTS; HOSPITAL PATIENT; HOSPITALIZATION; HOSPITALIZED CHILD; ORAL DRUG ADMINISTRATION; PSYCHOLOGY; RAGE; SLEEP; SOLUTION AND SOLUBILITY;

ADMINISTRATION, ORAL; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHILD; CHILD, HOSPITALIZED; FEMALE; HOSPITALIZATION; HUMANS; INPATIENTS; MALE; PHARMACEUTICAL SOLUTIONS; RAGE; RISPERIDONE; SLEEP; TREATMENT OUTCOME;

EID: 77955145410     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2010.00793.x     Document Type: Article

References (27)

1. Mick E, Spencer T, Wozniak J, Biederman J. Heterogeneity of irritability in attention-deficit/hyperactivity disorder subjects with and without mood disorders. Biol Psychiatry 2005, 58:576-582.
2. Wozniak J, Biederman J, Kwon A. How cardinal are cardinal symptoms in pediatric bipolar disorder? An examination of clinical correlates. Biol Psychiatry 2005, 58:583-588.
3. Leibenluft E, Charney DS, Towbin KE. Defining clinical phenotypes of juvenile mania. Am J Psychiatry 2003, 160:430-437.
4. McClellan J, Kowatch R, Findling RL. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2007, 46:107-125.
5. Waxmonsky JG, Pelham WE, Cummings M. The impact of manic-like symptoms on the multimodal treatment of pediatric attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2008, 18:573-588.
6. Dickstein DP, Towbin KE, Van Der Veen JW. Randomized double-blind placebo-controlled trial of lithium in youth with severe mood dysregulation. J Child Adolesc Psychopharmacol 2009, 19:61-73.
7. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007, 46:894-921.
8. Masters KJ, Bellonci C, Bennet W. Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions, with special reference to seclusion and restraint. J Am Acad Child Adolesc Psychiatry 2002, 41:4S-25S.
9. Vitiello B, Hill JL, Elia J, Cunningham E, McLeer SV, Behar D. P.r.n. medications in child psychiatric patients: a pilot placebo-controlled study. J Clin Psychiatry 1991, 52:499-501.
10. Joshi PT, Hamel L, Joshi AR, Capozzoli JA. Use of droperidol in hospitalized children. J Am Acad Child Adolesc Psychiatry 1998, 37:228-230.
11. Khan SS, Mican LM. A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents. J Child Adolesc Psychopharmacol 2006, 16:671-677.
12. Barzman DH, DelBello MP, Forrester JJ, Keck PE, Strakowski SM. A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed. J Child Adolesc Psychopharmacol 2007, 17:503-509.
13. McCracken JT, McGough J, Shah B. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002, 347:314-321.
14. Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 2002, 159:1337-1346.
15. Currier GW, Simpson GM. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry 2001, 62:153-157.
16. Grayson P, Carlson GA. The utility of a DSM-III-R-based checklist in screening child psychiatric patients. J Am Acad Child Adolesc Psychiatry 1991, 30:669-673.
17. Sprafkin J, Gadow KD, Salisbury H, Schneider J, Loney J. Further evidence of reliability and validity of the Child Symptom Inventory-4: parent checklist in clinically referred boys. J Clin Child Adolesc Psychol 2002, 31:513-524.
18. Carlson GA, Potegal M, Margulies D, Gutkovich Z, Basile J. Rages: what are they and who has them? J Child Adolesc Psychopharmacol 2009, 19:281-288.
19. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 1982, 39:879-883.
20. Klein DN, Ouimette PC, Kelly HS, Ferro T, Riso LP. Test-retest reliability of team consensus best-estimate diagnoses of axis I and II disorders in a family study. Am J Psychiatry 1994, 151:1043-1047.
21. Carlson GA. Treating the bipolar controversy: a tale of 2 children. Am J Psychiatry 2009, 166:18-24.
22. Birmaher B, Axelson D, Strober M. Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry 2006, 63:175-183.
23. Guy W. ECDEU Assessment Manual for Psychopharmacology 1976, 534-537. ed, Publication ADM 76-338, Rockville, MD, WU Department of Health, Education and Welfare
24. Simpson GM, Angus JWS. A rating scale for extrapyrimidal side effects. Acta Psychiatr Scand 1970, 212:S11-S19.
25. Bames TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989, 154:672-676.
26. Potegal M, Carlson GA, Margulies D, Basile J, Gutkovich ZA, Wall M. The behavioral organization, temporal characteristics, and diagnostic concomitants of " rage" outbursts in child psychiatry in-patients. Curr Psychiatry Rep 2009, 11:127-133.
27. Jensen PS, Youngstrom EA, Steiner H. Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. J Am Acad Child Adolesc Psychiatry 2007, 46:309-322.